The startup develops a medical device that utilizes nanoscale chemical engineering to stimulate cellular growth in the conjunctiva, creating a conducive environment for fibroblast cells to promote healing. This technology aims to treat cornea-related diseases, enabling individuals with corneal blindness to regain their eyesight through the use of implants and implantables.
Funding
$24.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current treatments for corneal blindness often rely on donor tissue, which is limited in supply and can lead to complications such as rejection. Existing synthetic solutions may not fully integrate with the surrounding tissue, leading to potential long-term issues.
Solution
CorNeat Vision develops biomimetic implants designed to permanently integrate with living tissue, addressing various ophthalmic and other medical challenges. Their core technology, EverMatrix™, is a synthetic, non-degradable porous material that mimics the extracellular matrix, promoting cellular proliferation and tissue integration without triggering adverse immune responses. This technology enables the creation of implants that mend, reinforce, and replace damaged tissue, offering a scalable alternative to donor tissue.
Target Audience
The primary target audience includes ophthalmic surgeons treating corneal blindness and other eye disorders, as well as medical professionals in need of solutions for soft tissue repair and regeneration.
Features
- EverMatrix™ material promotes biomechanical integration of implants with live tissue.
- Designed to avoid rejection by the body's immune system.
- Can be used to fabricate membranes and tissue barriers for controlled tissue regeneration.
- Provides permanent structural support to soft tissue.
- CorNeat KPro: A synthetic cornea designed to eliminate dependency on donor tissue.
- CorNeat EverPatch: A synthetic tissue substitute for ophthalmic surgical procedures.
- CorNeat eShunt: A glaucoma drainage device.
- CorNeat gPatch: A permanent periodontal regeneration membrane.